Latest Breaking News On - Pharma gmbh co - Page 5 : comparemela.com

CET- Comunicado - ;ultimaHoraHtml += + json.lead + ;}ultimaHoraHtml += ; document.getElementById( urgente ).innerHTML = ultimaHoraHtml; } } }); ·       Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry    Aachen, Germany, 7 April 2021 / News Aktuell– Grünenthal, a global science-based pharmaceutical company, today announced that Sustainalytics, a Morningstar company and a globally-recognized provider of ESG research, ratings and data, has assessed it as having overall medium ESG risk. In addition, Sustainalytics acknowledged that Grünenthal has a strong management of its ESG risks. This places Grünenthal in the top five percent of the global pharmaceuticals subsector.

United statesNordrhein westfalenGabriel baertschiFoundation for palliative careGrunenthal groupPharma gmbh coNews aktuellPharma gmbhPain patient centered innovation grantSocietal impactPain toolkitPalliative careGreat placeGlobal excellenceBusiness partnersEthics helpline